van Geffen Wouter H - Department of Respiratory Medicine, Medical Centre Leeuwarden

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 65 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Immunotherapy in Frail Non-Small-cell Lung Cancer Patients

Rolof GP Gijtenbeek,Anneloes L Noordhof, Oke D Asmara,Harry JM Groen,Wouter H van Geffen

The Lancetno. 10440 (2024): 1986

引用0浏览0WOS引用

Stage III NSCLC Treatment Options: Too Many Choices

Oke Dimas Asmara,Georgia Hardavella, Sara Ramella,Rene Horsleben Petersen, Ilona Tietzova,E. Christiaan Boerma, Eric Daniel Tenda, Asmaa Bouterfas, Marjolein A. Heuvelmans,Wouter H. van Geffen

BREATHE（2024）

引用0浏览0WOS引用

Impact of Triple Therapy Vs Dual Bronchodilator Therapy on Mortality Rates in COPD

Daniel J. Tan,Wouter H. van Geffen,E. Haydn Walters

CHESTno. 5 (2024): e158-e159

引用0浏览0WOS引用

Nationwide Real-World Overall Survival in Advanced EGFR Mutated NSCLC Using Different TKI

Rolof G. P. Gijtenbeek,Ronald A. M. Damhuis,Anthonie J. Van der Wekken,Lizza E. L. Hendriks,Harry J. M. Groen,Wouter H. Van Geffen

EUROPEAN RESPIRATORY JOURNAL (2023)

引用0浏览0引用

Survival of Patients with KRAS G12C Mutated Stage IV Non-Small Cell Lung Cancer with and Without Brain Metastases Treated with Immune Checkpoint Inhibitors

Esther M. Swart,Anneloes L. Noordhof,Ronald A. M. Damhuis,Peter W. A. Kunst,Dirk K. M. De Ruysscher,Lizza E. L. Hendriks,Wouter H. van Geffen,Mieke J. Aarts

Lung cancer (2023)

引用0浏览0WOS引用

Best First-Line Therapy for People with Advanced Non-Small Cell Lung Cancer, Performance Status 2 Without a Targetable Mutation or with an Unknown Mutation Status

R. G. Gijtenbeek,K. De Jong,B. J. Venmans, F. Van Vollenhoven,A. J. Van der Wekken,W. H. Van Geffen

Cochrane Database of Systematic Reviews（2023）

引用2浏览0WOS引用

ERS International Congress 2022: Highlights from the Thoracic Oncology Assembly

Maria Joana Catarata,Wouter H. Van Geffen,Radhika Banka,Beatriz Ferraz,Calvin Sidhu,Alan Carew,Lucia Viola,Rolof Gijtenbeek,Georgia Hardavella

ERJ Open Research（2023）

引用0浏览0WOS引用

Prognostic Implication of KRAS G12C Mutation in a Real-World KRAS-Mutated Stage IV NSCLC Cohort Treated with Immunotherapy in the Netherlands

Anneloes L. Noordhof,Esther M. Swart,Ronald A. M. Damhuis,Lizza E. L. Hendriks,Peter W. A. Kunst,Mieke J. Aarts,Wouter H. van Geffen

JTO clinical and research reports（2023）

引用0浏览0WOS引用

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP Statement on Management of Incidental Findings from Low Dose CT Screening for Lung Cancer

Emma L. O'Dowd,Ilona Tietzova,Emily Bartlett,Anand Devaraj, Juergen Biederer, Marco Brambilla,Alessandro Brunelli,Joanna Chorostowska-Wynimko,Herbert Decaluwe, Dirk Deruysscher,Walter De Wever, Matthew Donoghue,Aurelie Fabre, Mina Gaga,Wouter van Geffen, Georgia Hardavella,Hans-Ulrich Kauczor,Anna Kerpel-Fronius,Jan van Meerbeeck,Blin Nagavci,Ursula Nestle,Nuria Novoa,Helmut Prosch,Mathias Prokop,Paul Martin Putora,Janette Rawlinson,Marie-Pierre Revel,Annemiek Snoeckx,Giulia Veronesi,Rozemarijn Vliegenthart,Sabine Weckbach,Torsten G. Blum,David R. Baldwin

European Journal of Cardio-Thoracic Surgeryno. 4 (2023)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn